All Posts: Georgetown Lombardi
-
Going with Your Gut: Exploring the Microbiota’s Role in Colorectal Cancer Among the Young
(March 26, 2019) — When figures released by the American Cancer Society in 2017 showed a rise in colorectal cancer cases and deaths among young people, Benjamin Weinberg, MD, was alarmed, but not surprised. The young medical oncologist at Georgetown Lombardi Comprehensive Cancer Center is accustomed to treating men and women in their 60s and […]
Category: GUMC Stories
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release
-
Facing a Difficult Diagnosis, Why One Patient Chooses to Confront Cancer at Georgetown Lombardi
(March 7, 2019) — While living in Chattanooga, Tenn., Adam Skipper was one of the primary caregivers for his 69-year-old mother before pancreatic cancer took her life. In October 2018, almost two years to the day of his mother’s death, Skipper was diagnosed with the same disease. “It was just a massive blow,” says Lee […]
Category: GUMC Stories
-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
Category: GUMC Stories
-
Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 8, 2019) — A large national study examining a radiation treatment for prostate cancer — popular because it delivers a high dose of therapy in a very short time frame — supports its routine use. The study, conducted at cancer centers around the country including at Georgetown Lombardi Comprehensive Cancer Center, looks at long-term […]
Category: News Release
-
Study Finds HIV+ Cancer Patients Benefit From Immunotherapy
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 7, 2019) — The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Their study, published in JAMA Oncology, focused on whether a relatively new class of drugs called checkpoint inhibitors is both safe and […]
Category: News Release
-
Walking Warriors Host Grand Start Party, Launching 2019 Fundraising Efforts
(January 19, 2019) — The sobering realities of breast cancer brought dozens of cancer survivors and their friends and family to an event at the Lombardi atrium on a weekend pounded by snow. For years, Jeanne Mandelblatt, MD, MPH, has mobilized a close-knit, devoted team who raise visibility and awareness for breast cancer care and research […]
Category: GUMC Stories
-
First Patient in a Clinical Trial Using Her Own Blood to Personalize Treatment for Non-Hodgkin Lymphoma Experiencing Remission
(January 11, 2019) — The first cancer patient to be treated as part of the CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center is now in “complete remission.” Daisy Diggs, 57, of Laurel, Md., volunteered for the experimental treatment after a lengthy battle with stage-three non-Hodgkin lymphoma, a type […]
Category: GUMC Stories
-
Giving Patients A Voice in Breast Cancer Research
(January 4, 2019) — Soon after Hillary Stires, PhD, came to Georgetown Lombardi as a postdoctoral fellow, she started a grant application and asked for feedback from the Georgetown Breast Cancer Advocates (GBCA), a volunteer group of breast cancer survivors dedicated to supporting and promoting breast cancer research. Her experience was transformative. After Stires presented her plan […]
Category: GUMC Stories
-
Adams-Campbell, Internationally Renowned Cancer Epidemiologist, Named a 2018 Washingtonian of the Year
(December 19, 2018) — Lucile Adams-Campbell, PhD, professor of oncology and associate director for minority health and health disparities research at Georgetown Lombardi Comprehensive Cancer Center, was named a 2018 Washingtonian of the Year by Washingtonian magazine. The annual honor is bestowed on individuals who contribute to the city’s health, welfare, community service and cultural richness, and who have generally made […]
Category: GUMC Stories